1) A few further comments on COVID, in response to some comments:
Conversation
2) On the 1,000 person sample size:
a) challenge trials fix this
b) safety can be determined with ~1000 people; either you think COVID death >> 0.10% or the whole thing is stupid
c) efficacy was strongly expected
d) fine pay for 40k, it's a tiny fraction of the delay cost
Unfortunately the drug pipeline is more complicated than "give 1000, no die, good," when you're giving something to your entire population, you'd want multiple cohorts over time, there are contingencies of being in different environments than in testing, obviously need long term-
1
evidence that you're not just accidentally fucking a generation of people. So if you're complaining about the side effects, well, the likelihood increases in an accelerated pipeline.
1

